Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
   PubMed Web of Science ®Google Scholar
• Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997;8:755–63.
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, . NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010;49:725–36.
   PubMed Web of Science ®Google Scholar
• Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, . Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14:2191–9.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Volume VIII. IARC Sci Publ 2002;155:1–781.
   Google Scholar
• Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244–65.
   PubMed Web of Science ®Google Scholar
• Castellsague X, de Sanjose S, Aguado T, Louie KS, Bruni L, Munoz J, . HPV and cervical cancer in the 2007 report. Vaccine 2007;25(Suppl 3):C1–230.
   PubMedGoogle Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–9.
   PubMed Web of Science ®Google Scholar
• Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011;128:927–35.
   PubMed Web of Science ®Google Scholar
• Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 2003;88:63–73.
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, . Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048–56.
   PubMed Web of Science ®Google Scholar
• Usubutun A, Alemany L, Kucukali T, Ayhan A, Yuce K, de Sanjose S, . Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009;28:541–8.
   Google Scholar
• Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, . Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev 2010;19:2389–400.
   PubMed Web of Science ®Google Scholar
• Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G, . Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer 2010;103:209–16.
   PubMed Web of Science ®Google Scholar
• Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, . Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. BMC Cancer 2010;10:259.
   PubMed Web of Science ®Google Scholar
• Garland SM, Smith JS. Human papillomavirus vaccines: Current status and future prospects. Drugs 2010;70:1079–98.
   PubMed Web of Science ®Google Scholar
• Diaz ML. Prevention of cervical, vaginal, and vulval cancers: Role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine. Int J Womens Health 2010;1:119–29.
   PubMedGoogle Scholar
• Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, . The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16–26 years. J Infect Dis 2009;199:926–35.
   PubMed Web of Science ®Google Scholar
• Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27.
   PubMed Web of Science ®Google Scholar
• Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006;44:504–12.
   PubMed Web of Science ®Google Scholar
• Ramqvist T, Du J, Lunden M, Ahrlund-Richter S, Ferreira J, Marions L, . Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15–23-year-old women attending a youth health clinic in Stockholm, Sweden. Scand J Infect Dis 2011;43:115–21.
   PubMed Web of Science ®Google Scholar
• Dahlstrom LA, Ylitalo N, Sundstrom K, Palmgren J, Ploner A, Eloranta S, . Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer 2010;127:1923–30.
   PubMed Web of Science ®Google Scholar
• Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001;37:246–50.
   PubMed Web of Science ®Google Scholar
• Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, . Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620–3.
   PubMed Web of Science ®Google Scholar
• Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, . Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362–6.
   PubMed Web of Science ®Google Scholar